Literature DB >> 28124185

Mouse Models of Breast Cancer Share Amplification and Deletion Events with Human Breast Cancer.

Jonathan Rennhack1, Briana To1, Harrison Wermuth1, Eran R Andrechek2.   

Abstract

Breast tumor heterogeneity has been well documented through the use of multiplatform -omic studies in human tumors. However, there is no integrative database to capture the heterogeneity within mouse models of breast cancer. This project identifies genomic copy number alterations (CNAs) in 600 tumors across 27 major mouse models of breast cancer through the application of a predictive algorithm to publicly available gene expression data. It was found that despite the presence of strong oncogenic drivers in most mouse models, CNAs are extremely common but heterogeneous both between models and within models. Many mouse CNA events are largely conserved in human tumors and in the mouse we show that they are associated with secondary tumor characteristics such as tumor histology, metastasis, as well as enhanced oncogenic signaling. These data serve as an important resource in guiding investigators when choosing a mouse model to understand the gene copy number changes relevant to human breast cancer.

Entities:  

Keywords:  Breast cancer; Copy number variation; Gene expression; Metastasis; Mouse model

Mesh:

Year:  2017        PMID: 28124185      PMCID: PMC5313323          DOI: 10.1007/s10911-017-9374-y

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  51 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  A pathway-based classification of human breast cancer.

Authors:  Michael L Gatza; Joseph E Lucas; William T Barry; Jong Wook Kim; Quanli Wang; Matthew D Crawford; Michael B Datto; Michael Kelley; Bernard Mathey-Prevot; Anil Potti; Joseph R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-24       Impact factor: 11.205

3.  Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes.

Authors:  Anne Helmrich; Karen Stout-Weider; Klaus Hermann; Evelin Schrock; Thomas Heiden
Journal:  Genome Res       Date:  2006-09-05       Impact factor: 9.043

4.  Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

Authors:  Charles L Vogel; Melody A Cobleigh; Debu Tripathy; John C Gutheil; Lyndsay N Harris; Louis Fehrenbacher; Dennis J Slamon; Maureen Murphy; William F Novotny; Michael Burchmore; Steven Shak; Stanford J Stewart; Michael Press
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

Review 5.  HER2 as a prognostic factor in breast cancer.

Authors:  S Ménard; S Fortis; F Castiglioni; R Agresti; A Balsari
Journal:  Oncology       Date:  2001       Impact factor: 2.935

6.  Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.

Authors:  C Escot; C Theillet; R Lidereau; F Spyratos; M H Champeme; J Gest; R Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

7.  Prediction and genetic demonstration of a role for activator E2Fs in Myc-induced tumors.

Authors:  Kenichiro Fujiwara; Inez Yuwanita; Daniel P Hollern; Eran R Andrechek
Journal:  Cancer Res       Date:  2011-01-18       Impact factor: 12.701

8.  Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.

Authors:  H Shimada; D O Stram; J Chatten; V V Joshi; Y Hachitanda; G M Brodeur; J N Lukens; K K Matthay; R C Seeger
Journal:  J Natl Cancer Inst       Date:  1995-10-04       Impact factor: 13.506

9.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

Authors:  Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

10.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Authors:  Jason I Herschkowitz; Karl Simin; Victor J Weigman; Igor Mikaelian; Jerry Usary; Zhiyuan Hu; Karen E Rasmussen; Laundette P Jones; Shahin Assefnia; Subhashini Chandrasekharan; Michael G Backlund; Yuzhi Yin; Andrey I Khramtsov; Roy Bastein; John Quackenbush; Robert I Glazer; Powel H Brown; Jeffrey E Green; Levy Kopelovich; Priscilla A Furth; Juan P Palazzo; Olufunmilayo I Olopade; Philip S Bernard; Gary A Churchill; Terry Van Dyke; Charles M Perou
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  11 in total

Review 1.  Using gene expression data to direct breast cancer therapy: evidence from a preclinical trial.

Authors:  Shams Reaz; Deimante Tamkus; Eran R Andrechek
Journal:  J Mol Med (Berl)       Date:  2018-01-08       Impact factor: 4.599

Review 2.  How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective.

Authors:  Matthew R Swiatnicki; Eran R Andrechek
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-06-21       Impact factor: 2.673

3.  Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?

Authors:  Nancy Krieger; Sheida Nabavi; Pamela D Waterman; Ninah S Achacoso; Luana Acton; Stuart J Schnitt; Laurel A Habel
Journal:  Cancer Causes Control       Date:  2018-02-09       Impact factor: 2.506

4.  Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures.

Authors:  Christina Ross; Karol Szczepanek; Maxwell Lee; Howard Yang; Cody J Peer; Jessica Kindrick; Priya Shankarappa; Zhi-Wei Lin; Jack D Sanford; William D Figg; Kent W Hunter
Journal:  Mol Cancer Res       Date:  2020-06-08       Impact factor: 5.852

Review 5.  Triple-negative breast cancer and the potential for targeted therapy.

Authors:  Jing-Ru Jhan; Eran R Andrechek
Journal:  Pharmacogenomics       Date:  2017-11-02       Impact factor: 2.533

6.  Integrated analyses of murine breast cancer models reveal critical parallels with human disease.

Authors:  Jonathan P Rennhack; Briana To; Matthew Swiatnicki; Caleb Dulak; Martin P Ogrodzinski; Yueqi Zhang; Caralynn Li; Evan Bylett; Christina Ross; Karol Szczepanek; William Hanrahan; Muthu Jayatissa; Sophia Y Lunt; Kent Hunter; Eran R Andrechek
Journal:  Nat Commun       Date:  2019-07-22       Impact factor: 14.919

7.  Normal mammary gland development after MMTV-Cre mediated conditional PAK4 gene depletion.

Authors:  Parisa Rabieifar; Ting Zhuang; Tânia D F Costa; Miao Zhao; Staffan Strömblad
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

Review 8.  Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo.

Authors:  Sherif Attalla; Tarek Taifour; Tung Bui; William Muller
Journal:  Oncogene       Date:  2020-11-24       Impact factor: 9.867

9.  Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers.

Authors:  Daniel P Hollern; Matthew R Swiatnicki; Eran R Andrechek
Journal:  PLoS Genet       Date:  2018-01-18       Impact factor: 5.917

10.  Low E2F2 activity is associated with high genomic instability and PARPi resistance.

Authors:  Jonathan P Rennhack; Eran R Andrechek
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.